Monday, 23 September 2019

Japan News

  • Otsuka launches English website for global viewers

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

    Singapore: Japan-based Otsuka Pharmaceutical launched a newly designed English corporate website in collaboration with an Amsterdam-based creative agency. The new site reflects Otsuka's phi...Read more

  • Takeda diabetes drug gets China's import license

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Aug, 2013

    Singapore: China's State Food and Drug Administration (SFDA) issued an Import Drug License (IDL) for Takeda's type 2 diabetes drug Nesina (alogliptin). Orally administered dipeptidyl pept...Read more

  • Japan Minister: Dont be afraid of new science strategy

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Japanese scientists are skeptical about the country's new strategy for economic growth, which includes an emphasis on applied biomedical research. Several life science organizati...Read more

  • Takeda appoints first-ever non-Japanese president

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Dec, 2013

    Singapore: In an effort to speedup business expansion in emerging nations, Japan's largest drug maker, Takeda Pharmaceuticals has chosen its new president from a rival company. The company...Read more

  • FDA panel approves new obesity drug, Eisai to market it

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

    Cambridge, Massachusetts: Lorcaserin, a chemical drug that aims to control obesity by altering the serotonin receptors in the brain that control hunger pangs, developed by Arena Pharmaceuti...Read more

  • Japan pharma to grow at 2% CAGR from 2013-20

    Japan |  Analysis | By BioSpectrum Bureau  | 0 Comment | 11 Jul, 2013

    Singapore: Simplification of the regulatory process will prove to be the key to the growth of the pharma market in Japan, claimed a recent report by Research and Markets. The CountryFocus ...Read more

  • APAC healthcare industry becomes cloud friendly

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 07 Nov, 2013

    Singapore: A recent report presented by Frost & Sullivan has said that the healthcare industry in Asia Pacific is embracing the full gamut of cloud provided services from infrastructure...Read more

  • Eisai signs agreement with Epizyme and Roche

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Eisai has signed an agreement with Epizyme and Roche Molecular Systems to collaborate on the development of a companion diagnostic to help Eisai and Epizyme identify patients fo...Read more

  • Takeda, Lundbeck to present depression study data

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 20 May, 2013

    Singapore: Takeda Pharmaceutical and H Lundbeck will be presenting new data from four studies that evaluated effectiveness in treating the overall symptoms of depression in patients taking ...Read more

  • Japan Vaccine begins operation

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Jul, 2012

    Singapore: Japan Vaccine, a joint venture created by equal investments from Daiichi Sankyo and GlaxoSmithKline, started its operation from July 3, 2012. Japan Vaccine will hold all develop...Read more

  • Japan approves generic drug for osteoporosis

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 28 Dec, 2012

    Singapore: Actonel 75 mg tablets and Benet 75 mg tablets, a once-monthly formulation of risedronate sodium hydrate (generic name) for the treatment of osteoporosis by Ajinomoto Pharmaceutic...Read more

  • Mitsubishi proton system aids cancer therapy in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

    Singapore: Mitsubishi Electric to supply its proton beam therapy system for cancer treatment to Tsuyama Chuo Hospital, Japan, led by Mr Yoshinori Ukita, president of Tsuyama Jifu Group, in ...Read more

  • Japan approves reimbursement for Edwards' Sapien XT valve

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 22 Aug, 2013

    Singapore: Edwards Lifesciences, makers of heart valves and hemodynamic monitoring, has announced that Japan's Central Social Insurance Medical Council (Chuikyo) has approved the recommenda...Read more

  • MTPC completes acquisition of Medicago

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 19 Sep, 2013

    Singapore: Japanese drugmaker Mitsubishi Tanabe Pharma Corporation (MTPC) and Canada-based Medicago, a clinical-stage biopharmaceutical company developing novel vaccines and therapeutic pro...Read more

  • Bionest and Scisive merge together

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 31 Dec, 2012

    Singapore: Bionest Partners and Scisive Consulting have merged to form a global strategy and management consulting firms for the life science industries. The merged companies will operate u...Read more

  • Shionogi launches London headquarter

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jul, 2012

    Singapore: Japan-based pharmaceutical company Shionogi has launched its new European Headquarters in London, UK, to be called Shionogi Limited. The new headquarters will form a new era for ...Read more

  • A time to rethink talent management

    Japan |  Opinion | By BioSpectrum Bureau  | 0 Comment | 29 May, 2012

            Year 2011 was an action-packed-year for HR professionals in Asia Pacific life sciences industry. It tested their skills to keep pace with the high level of investment and ...Read more

  • Astellas, Merck enter co-promotion deal in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 03 Sep, 2013

    Singapore: Astellas Pharma and MSD KK, the Japan unit of US pharma giant Merck, have entered into a co-promotion agreement for ipragliflozin L-proline, a SGLT2 inhibitor, in Japan. Earlier ...Read more



Podcast

 

Survey Box

Is Pharma innovation getting inhibited in APAC?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls